Vancouver, BC, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that it has engaged Danayi Capital Corp. (“Danayi”) to provide digital marketing services for a two (2) month term commencing on February 9, 2026, in consideration of an up-front payment of USD$125,000. Danayi shall utilize digital marketing and online advertisements through www.wallstreetlogic.com. Danayi does not currently own any interest, directly or indirectly, ...

Rocket Doctor is now in-network with another major insurer for commercial employer-sponsored health plans across California.The new agreement includes approximately 175,000 members in California under one major insurer, extending Rocket Doctor’s total in-network reach to over 13 million members coast to coast.The agreement further strengthens Rocket Doctor’s presence in one of the largest U.S. healthcare markets and supports its national expansion strategy.The partnership enhances payer mix and positions th ...

Core Viewpoint - Rocket Doctor AI Inc. has successfully closed a non-brokered private placement, raising approximately C$5,200,000 through the issuance of 7,428,571 units at C$0.70 per unit, which will support the company's growth strategy, particularly in the U.S. market [1][2]. Group 1: Offering Details - The offering consisted of units, each comprising one common share and one warrant, with warrants exercisable at C$0.85 until January 22, 2027 [2]. - The offering was completed under the listed issuer financing exemption, meaning the securities are not subject to a hold period under Canadian securities laws [3]. - The company paid a cash commission of C$198,800 to finders and issued 284,000 non-transferrable warrants, also exercisable at C$0.85 until January 22, 2027 [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated towards digital marketing, customer acquisition, operating and administrative expenses, research and development, and general working capital [5]. Group 3: Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions aimed at improving access to quality healthcare throughout the patient journey, leveraging a clinically validated decision support system [7]. - The company has empowered over 300 MDs to manage more than 700,000 patient visits, enhancing efficiency and expanding patient access to care [8]. - The technology aims to reduce administrative burdens and improve physician-patient interactions, particularly targeting underserved communities in Canada and supporting patients on Medicaid and Medicare in the U.S. [9][10].

Core Viewpoint - Rocket Doctor AI Inc. has increased its non-brokered private placement offering to a maximum of $4.5 million due to high demand, with each unit priced at $0.70 [1] Group 1: Offering Details - The offering has been upsized from its initial announcement on January 9, 2025, and the amended offering document is available on the company's profile and website [2] - All other terms of the offering remain unchanged despite the increase in the maximum gross proceeds [1] Group 2: Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions designed to enhance accessibility throughout the patient journey, featuring the Global Library of Medicine (GLM) as a key component [4] - The company has empowered over 300 physicians to manage more than 700,000 patient visits, enabling doctors to launch and manage virtual or hybrid practices [5] - The technology aims to reduce administrative burdens, improve care consistency, and enhance physician-patient interactions, particularly targeting underserved communities in Canada and patients on Medicaid and Medicare in the U.S. [6]

Vancouver, BC, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that the Company has granted an aggregate 75,000 stock options, exercisable at $0.74 per share and valid for a term of three years, and an aggregate 212,148 restricted share units, valid for a term of three years, to consultants of the Company. The stock options and restricted share units are issued pursuant to the Company’s share compensation plans and are subject ...

Core Viewpoint - Rocket Doctor AI Inc. is initiating a non-brokered private placement to raise a minimum of approximately $3,000,000 through the sale of 4,285,715 units at a price of $0.70 per unit [1][6] Group 1: Offering Details - Each unit consists of one common share and one warrant, with the warrant allowing the purchase of one common share at an exercise price of $0.85 for 12 months post-closing [2] - The offering is conducted under the LIFE Exemption, allowing it to be available to purchasers in all Canadian provinces except Quebec, with no hold period for the issued units [3] - The offering is expected to close on or about January 19, 2026, subject to conditions including receiving subscriptions for the minimum amount and necessary approvals [6] Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for digital marketing, customer acquisition, operating and administrative expenses, research and development, and general working capital [5] Group 3: Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions aimed at improving access to quality healthcare throughout the patient journey, supported by a clinically validated decision support system [8] - The company has empowered over 300 MDs to manage more than 700,000 patient visits, enhancing efficiency and expanding patient access to care [9] - The technology aims to reduce administrative burdens and improve physician-patient interactions, particularly targeting underserved communities in Canada and supporting patients on Medicaid and Medicare in the U.S. [10][11]

Core Viewpoint - Rocket Doctor AI Inc. has successfully completed the acquisition of Alea Health Holdings Ltd., enhancing its digital health platform and supporting its mission to improve access to high-quality healthcare, particularly for underserved communities across North America [1][6]. Transaction Overview - The acquisition involved Rocket Doctor AI acquiring 100% of Alea's ordinary shares through a cash payment of US $15,000 and the issuance of 285,712 common shares valued at CAD $0.70 each [4]. - The company will also assume Alea's obligations under a Simple Agreement for Future Equity (SAFE Note), with a principal balance of US $180,000 to be paid in monthly installments of US $22,500 [5]. Strategic Importance - The acquisition is seen as a significant step in Rocket Doctor AI's strategy to build a scalable, physician-led digital health ecosystem, integrating Alea's technology to enhance clinical workflows and decision support [2][3]. - Alea's technology will be incorporated into Rocket Doctor AI's platform, aiming to improve care consistency and expand access to healthcare for patients, especially in remote areas [3][10]. Company Background - Rocket Doctor AI delivers AI-powered healthcare solutions designed to enhance the patient journey, with a focus on evidence-based care and improving patient outcomes [8][10]. - The company has empowered over 300 MDs to manage more than 700,000 patient visits, emphasizing efficiency and autonomy for physicians [9].

Core Insights - Rocket Doctor AI Inc. has partnered with the CAN Health Network to test its AI-powered Clinical Decision Support System (CDSS) in Alberta, aiming to enhance primary care delivery [1][8] - The project will run from November 2025 to March 2026, involving approximately 20 clinicians and potentially leading to a full provincial rollout in 2026 [2][8] - The initiative addresses critical challenges in Alberta's healthcare system, including staffing shortages and limited access to primary care [4][5] Project Details - The CDSS will be implemented in three phases: AI-powered patient intake via a chatbot, real-time clinician support during visits, and integration with electronic medical records (EMRs) [3][8] - Key anticipated outcomes include a 25-40% reduction in physician intake time and improved patient satisfaction through enhanced communication [5][8] Strategic Importance - This collaboration is seen as a significant milestone for Rocket Doctor AI, aligning with its mission to empower healthcare providers and improve patient outcomes [6][7] - The project is supported by funding from the CAN Health Network, which aims to facilitate the adoption of innovative healthcare solutions in Canada [7][8] Technological Framework - Rocket Doctor AI's Global Library of Medicine (GLM) serves as a clinically validated decision engine, developed with input from numerous physicians to assist in triage and evidence-based care planning [3][12] - The platform will be hosted in secure Canadian data centers, ensuring compliance with relevant health information regulations [6][12] Future Prospects - The initiative aims to scale across Alberta's 4,400 providers, with the potential for broader implementation beyond the province [6][7] - The partnership underscores a commitment to modernizing healthcare delivery through responsible AI innovation, addressing the needs of overburdened clinicians [7][14]

Company Leadership Change - Christopher Cherry will assume the role of Interim Chief Financial Officer, replacing David Worner, effective December 8, 2025 [1] - The company expresses gratitude to Mr. Worner for his contributions and wishes him well in future endeavors [1] Stock Options and Restricted Share Units - The company has granted a total of 579,028 stock options, exercisable at $0.84 per share, valid for a term of three to five years [2] - Additionally, 931,112 restricted share units have been issued, valid for a term between two to five years, to executive officers, directors, and consultants [2] - These stock options and restricted share units are part of the company's share compensation plans and are subject to vesting conditions [2] Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions aimed at improving access to high-quality healthcare throughout the patient journey [3] - The company's technology includes the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from numerous physicians globally [3] Digital Health Platform - Rocket Doctor Inc. operates an AI-powered digital health platform and marketplace, enabling over 300 MDs to provide care for more than 700,000 patient visits [4] - The technology allows doctors to independently launch and manage virtual or hybrid in-person practices, enhancing efficiency and patient access [4] Commitment to Underserved Communities - The company aims to reduce administrative burdens and improve physician-patient interactions, particularly in underserved, rural, and remote communities in Canada [5] - It also supports patients on Medicaid and Medicare in the United States, focusing on making healthcare more scalable, equitable, and patient-centered [5]

Rocket Doctor and Toronto Metropolitan University (TMU) have formed a strategic partnership to leverage the independent physicians on the Rocket Doctor platform to expand clinical education opportunities across TMU’s Medical School.Both organizations will collaborate on joint communications and create streamlined pathways for physicians on Rocket Doctor to engage with TMU and apply for clinical faculty roles.Rocket Doctor will promote and facilitate clinical faculty appointments, verify physician status, su ...